Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 08:24 am Sale | 2020-12-31 | 13G | GlycoMimetics, Inc. GLYC | Camber Capital Management LP | 22,000 4.600% | -13,000 (-37.14%) | Filing History |
| 2021-02-16 08:22 am Sale | 2020-12-31 | 13G | Change Healthcare Inc. CHNG | Camber Capital Management LP | 13,000,000 4.270% | -3,600,000 (-21.69%) | Filing History |
| 2021-02-16 08:21 am Purchase | 2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 2,555,000 6.430% | 155,000 (+6.46%) | Filing History |
| 2021-02-16 08:20 am Purchase | 2020-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 5,000,000 6.650% | 1,000,000 (+25.00%) | Filing History |
| 2021-02-16 08:19 am Sale | 2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Camber Capital Management LP | 0 0.000% | -118,000 (Position Closed) | Filing History |
| 2020-11-30 10:57 am Purchase | 2020-11-20 | 13G | AVROBIO, Inc. AVRO | Camber Capital Management LP | 261,111 7.560% | 261,111 (New Position) | Filing History |